The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Sodium Phosphates
sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous · SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 276 mg/mL; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS 142 mg/mL · Injection, Solution · Intravenous · Civica, Inc.
NDC 72572-0309-25 · 25 VIAL, SINGLE-DOSE in 1 TRAY / 5 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$403.25
Reported to Texas DSHS · 2026 annual filing · Civica, Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- American Regent, Inc.United Stateslabel · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA218314
- TE code
- AP
- Approval date
- Jun 21, 2024
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| American Regent, Inc. | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 276 mg/mL; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS 142 mg/mL | Aug 26, 2026 | Sep 3, 2026 |
| Civica, Inc. | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 276 mg/mL; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS 142 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| American Regent, Inc. | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 142 mg/mL; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS 276 mg/mL | Jul 22, 2026 | Aug 22, 2026 |
| Civica, Inc. | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 142 mg/mL; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS 276 mg/mL | Jul 22, 2026 | Aug 19, 2026 |
| American Regent, Inc. | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS 142 mg/mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 276 mg/mL | Jul 15, 2026 | Jul 18, 2026 |
| Civica, Inc. | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS 142 mg/mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 276 mg/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Sodium Phosphates — NDC 72572-0309-25," retrieved September 3, 2026, https://drugdashboards.com/drug/72572030925.
Free to cite with attribution — see how the data is put together.